151 related articles for article (PubMed ID: 19424632)
1. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.
Ronkainen H; Vaarala MH; Kauppila S; Soini Y; Paavonen TK; Rask J; Hirvikoski P
Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
6. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients.
Lua J; Qayyum T; Edwards J; Roseweir AK
Urol Int; 2018; 101(2):190-196. PubMed ID: 30089311
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis.
Leite KR; Reis ST; Junior JP; Zerati M; Gomes Dde O; Camara-Lopes LH; Srougi M
Diagn Pathol; 2015 Oct; 10():189. PubMed ID: 26470780
[TBL] [Abstract][Full Text] [Related]
10. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
[TBL] [Abstract][Full Text] [Related]
12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.
Li W; Liu M; Feng Y; Xu YF; Che JP; Wang GC; Zheng JH; Gao HJ
Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926
[TBL] [Abstract][Full Text] [Related]
14. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
[TBL] [Abstract][Full Text] [Related]
15. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
16. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
Can C; Acikalin MF; Ozen A; Dundar E
Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
[TBL] [Abstract][Full Text] [Related]
18. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T
Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
